NorthWest Biotherapeutics Inc (NWBO)

[datafarer]

Having had the opportunity to ask LL a few questions directly, I do think she is rallying support within the community and then to get FDA approve usage of external control. That’s how she is positioning all these talks. I do believe that it’s significant move and hint on her part. The slide from today’s presentation which talks about 3 different analyses was very interesting and shows the what all they are doing. I hope they hit stat sig on all the flows (although I think it’s stat sig just for a subgroup - but I want to be wrong)

The only question that’s bothering me is “if you so strongly believe in the results then why not rerun a proper p3 trial with support from top 5 institutes” Actually, this is a specific question from a Neuro oncologist who I tried to debate this with. I do not have a good answer for this.

I know some of you might say well release this as SOC and then keep on running parallel trials. I get that but with all yhe time that’s being wasted the trial might already be half way over by now.

Maybe dr Bala and others can chime in.